Emerald Investment Advisers »

United Therapeutics Corporation shares owned by Emerald Investment Advisers

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Emerald Investment Advisers from 13F filings

Historical chart of Emerald Investment Advisers investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Emerald Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Emerald Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 9.3k 541.83

More positions owned by Emerald Investment Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Eli Lilly & Co. (LLY)
Lam Research Corp Com New (LRCX)
Ishares Tr Msci Eafe Etf (EFA)
Morgan Stanley Com New (MS)
Ligand Pharmaceuticals Com New (LGND)

View all positions for Emerald Investment Advisers

Top funds holding United Therapeutics Corporation

BlackRock
venBio Select Advisor
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Wellington Management Company
Geode Capital Management
Henderson Group
Jupiter Topco
Caption Management
Citadel Advisors
Susquehanna International
Norges Bank Investment Management
Assetmark

View all funds holding United Therapeutics Corporation